Who is sponsoring NCT07380945?

NCT07380945 is sponsored by Peking University Third Hospital.

What condition does NCT07380945 study?

NCT07380945 studies Central Compartment Atopic Disease (CCAD).

What drugs are being tested in NCT07380945?

Interventions: Computer Tomography.

What is the status of NCT07380945?

NCT07380945 is currently NOT_YET_RECRUITING.

Last reviewed 2026-02-02 · How we verify

Development of A Multi-section Olfactory Cleft Opacity Staging System in Patients With CCAD

NCT07380945 NOT_YET_RECRUITING

This study aims to develop a modified CT scoring system to evaluate the association between olfactory cleft obstruction patterns and olfactory dysfunction in patients with central region atopic disease (CCAD). The main questions that the clinical trial aims to answer are: Can this modified CT scoring system be used to assess the degree of olfactory impairment in patients with CCAD? How well does the modified CT score correlate with the patient's olfaction compared to the traditional CT score?

Details

Lead sponsor	Peking University Third Hospital
Status	NOT_YET_RECRUITING
Enrolment	120
Start date	Sun Mar 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Central Compartment Atopic Disease (CCAD)

Interventions

Computer Tomography

Countries

China